Insights into the Global Biofilms Treatment Market Evolution: Past, Present, and Future – ResearchAndMarkets.com




Insights into the Global Biofilms Treatment Market Evolution: Past, Present, and Future – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biofilms Treatment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The report titled “World Biofilms Treatment Market – Recent Past, Current & Future Analysis” provides a comprehensive analysis of the global biofilms treatment market, focusing on different geographic regions including the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

The study covers the recent past, current, and future trends in the market for the years 2022 through 2030, examining the annual sales in US$ Thousand and the Compound Annual Growth Rate (CAGR) for the specified period.

The report also presents historic reviews for biofilms treatment in different regions for the years 2014 through 2021, offering valuable insights into market evolution over the years.

It further includes analyses of various segments within the biofilms treatment market, such as gauzes & dressings, debridement equipment, gels, ointments & sprays, grafts & matrices, wipes, pads & lavage solutions, burns & other open wounds, traumatic & surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, hospitals, ASCs & wound care centers, home care settings, and other end-uses, considering their independent sales and growth prospects.

Global Biofilms Treatment Market to Reach $3.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biofilms Treatment estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2022-2030.

Gauzes & Dressings, one of the segments analyzed in the report, is projected to record 6.9% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Debridement Equipment segment is readjusted to a revised 5.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $612.1 Million, While China is Forecast to Grow at 10.8% CAGR

The Biofilms Treatment market in the U.S. is estimated at US$612.1 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$858.7 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

What’s New for 2023?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its ‘bumpy’ reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies – Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

A selection of companies mentioned in this report includes

• Acelity (A Part Of 3M)
• Advancis Medical
• Arobella Medical, Llc
• Braun Melsungen Ag
• Coloplast A/S
• Convatec Group Plc
• Integra Lifesciences Holdings Corporation
• Kerecis
• Medaxis Ag
• Medline Industries, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/evtmqb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900